Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

NATerminatedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

October 21, 2014

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
Hearing LossPartial DeafnessHearing DisordersEar DiseasesOtorhinolaryngologic Diseases
Interventions
DEVICE

HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode

HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be implanted in adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss).

DEVICE

EAS sound processor

Patients with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) implanted with HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be fitted with the EAS sound processor.

Trial Locations (11)

10016

New York University Langone Medical Center, New York

20007

Georgetown University School of Medicine, Washington D.C.

33606

Tampa Bay Hearing and Balance Center, Tampa

37232

Vanderbilt Bill Wilkerson Center, Nashville

40536

University of Kentucky Medical Center, Lexington

55905

Mayo Clinic Rochester, Rochester

63110

Washington University, St Louis

64111

Midwest Ear Institute/St. Luke's Health System, St Louis

65201

University of Missouri, Columbia

73104

Oklahoma Ear Institute, Oklahoma City

78731

Austin Ear, Nose & Throat Clinic, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Advanced Bionics

INDUSTRY

NCT02189798 - Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness | Biotech Hunter | Biotech Hunter